Concepedia

Publication | Open Access

Early vedolizumab trough levels predict combined endoscopic and clinical remission in inflammatory bowel disease

DOIFull Paper Access

27

Citations

22

References

2019

Year

Jurij Hanžel, Nejc Sever, Ivan Ferkolj, Borut Štabuc, Nataša Smrekar, Tina Kurent, Matic Koželj, Gregor Novak, Griet Compernolle, Sophie Tops,
United European Gastroenterology Journal

Abstract

Early vedolizumab trough levels predicted combined endoscopic and clinical remission highlighting their possible use in clinical practice.

References

YearCitations

Page 1